Yourgene Health - A break above 13.7p would target 16.9p
Yourgene Health PLC, formerly Premaitha Health PLC, is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company's product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases.
Market Cap - £71.88 Million
The shares are trading in a well-established range between 10.50p – 13.7p. The shares appear to be heading to the upper boundary of the range and we expect an eventual break of resistance at 13.70p. A break of resistance at 13.7p should lead to more upside over the medium term. Our upside target is 16.9p, which is around 40% higher than the current price. A break below support at 10.5p would invalidate the bullish view.
Interested in UK Small Caps?
Join our free Telegram channel for up to date analysis on the best small-cap opportunities in the UK right now.
t.me/UK_SmallCaps
Market Cap - £71.88 Million
The shares are trading in a well-established range between 10.50p – 13.7p. The shares appear to be heading to the upper boundary of the range and we expect an eventual break of resistance at 13.70p. A break of resistance at 13.7p should lead to more upside over the medium term. Our upside target is 16.9p, which is around 40% higher than the current price. A break below support at 10.5p would invalidate the bullish view.
Interested in UK Small Caps?
Join our free Telegram channel for up to date analysis on the best small-cap opportunities in the UK right now.
t.me/UK_SmallCaps
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.